Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (283)
- COVID-19 (163)
- Safety monitoring and information (108)
- Compliance and enforcement (79)
- Legislation (77)
- Manufacturing (58)
- Vaping hub (56)
- Labelling and packaging (38)
- Import and export (33)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (20)
- Weight loss products (15)
- Shortages and supply disruptions (13)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
1262 result(s) found, displaying 801 to 825
-
Safety updatesHealth professionals are advised that the Product Information (PI) documents for sertraline have been updated to include microscopic colitis as a potential adverse effect of unknown frequency based on post-marketing experience.
-
Safety updatesThe recommended duration of contraception after finishing tamoxifen treatment has been extended from two months to nine months.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesInteraction between TGA and AHPRA advertising guidelines
-
Safety updatesConsumer goods with button batteries
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to Sydney company Aidacare Pty Ltd (Aidacare).
-
Media releasesThe TGA is seriously concerned about misleading information that has been broadcast on radio stations providing a distorted picture of the safety of COVID-19 vaccines.
-
Media releasesThe TGA has implemented arrangements to facilitate the communication of information about approved COVID-19 vaccines.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has issued three infringement notices to a Queensland man for the alleged unlawful importation of a medicine containing Armodafinil.
-
Media releasesThe TGA has issued two infringement notices to a dentist from Western Australia for the alleged unlawful importation of cosmetic injectables.
-
Media releasesThe TGA has issued two infringement notices to Perth-based company V P & Associates Pty Ltd (V P & Associates), for alleged unlawful advertising of a medical device in relation to SARS-CoV-2 Human Coronavirus.
-
-
News articlesWe are improving the Medicine Shortages IT System.
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA is warning sponsors not to advertise listed medicines that are not included in the ARTG with permitted indications
-
News articlesRemaking of standards and legislative instruments for human cell and tissue (HCT) products, blood and blood components
-
Media releasesPeter Evans Chef Pty Ltd fined $79,920 for alleged unlawful advertising
-
News articlesUpdated storage conditions for the Pfizer COVID-19 vaccine
-
News articlesThe TGA granted a provisional determination to GlaxoSmithKline Australia Pty Ltd in relation to the monoclonal antibody treatment, SOTROVIMAB (GSK4182136) on 14 April 2021
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines
-
BlogEven if you're familiar with your pet's medicine, the advice is clear: if a product is labelled 'for animal use only', do not take it.
-
Compliance undertakingsEnforceable Undertaking given by Chemforce Pty Ltd to the Department of Health